48,833
edits
Difference between revisions of "Biphasic hyalinizing psammomatous renal cell carcinoma"
Jump to navigation
Jump to search
Biphasic hyalinizing psammomatous renal cell carcinoma (view source)
Revision as of 17:52, 25 March 2024
, 25 Marchno edit summary
(more) |
|||
| Line 1: | Line 1: | ||
'''Biphasic hyalinizing psammomatous renal cell carcinoma''', abbreviated '''BHP RCC''', is a rare type of [[renal cell carcinoma]] with mutations in neurofibromin 2.<ref name=pmid32217839>{{cite journal |authors=Argani P, Reuter VE, Eble JN, Vlatkovic L, Yaskiv O, Swanson D, Dickson BC, Antonescu CR, Matoso A, Gagan J, Palsgrove DN |title=Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma (BHP RCC): A Distinctive Neoplasm Associated With Somatic NF2 Mutations |journal=Am J Surg Pathol |volume=44 |issue=7 |pages=901–916 |date=July 2020 |pmid=32217839 |pmc=7350624 |doi=10.1097/PAS.0000000000001467 |url=}}</ref> | '''Biphasic hyalinizing psammomatous renal cell carcinoma''', abbreviated '''BHP RCC''', is a rare type of [[renal cell carcinoma]] with mutations in neurofibromin 2.<ref name=pmid32217839>{{cite journal |authors=Argani P, Reuter VE, Eble JN, Vlatkovic L, Yaskiv O, Swanson D, Dickson BC, Antonescu CR, Matoso A, Gagan J, Palsgrove DN |title=Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma (BHP RCC): A Distinctive Neoplasm Associated With Somatic NF2 Mutations |journal=Am J Surg Pathol |volume=44 |issue=7 |pages=901–916 |date=July 2020 |pmid=32217839 |pmc=7350624 |doi=10.1097/PAS.0000000000001467 |url=}}</ref> | ||
It is not recognized as a subtype of RCC by the WHO of 2022.<ref name=pmid35971742/> | |||
==General== | ==General== | ||